The leaf extract of Ginkgo Biloba L. suppresses oxidized LDL-stimulated fibronectin production through an antioxidant action in rat mesangial cells

British Journal of Pharmacology

Volumn 142, Issue 3, 2004, Pages 419-424

  Akiba, Satoshi ^a   Chiba, Masahiro ^a   Mukaida, Yuki ^a   Tamura, Akira ^b   Sato, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b Chukyo Women's University   (Japan)

Author keywords

Extracellular matrix protein; Fibronectin; Ginkgo biloba leaf extract; Mesangial cell; Oxidized LDL; Reactive oxygen species

Indexed keywords

7 OXOCHOLESTEROL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBRONECTIN; GINKGO BILOBA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GINKGO BILOBA; MESANGIUM CELL; NONHUMAN; OXIDATION; PLANT LEAF; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; FIBRONECTINS; GINKGO BILOBA; GLOMERULAR MESANGIUM; LIPOPROTEINS, LDL; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

EID: 3042794591     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705805     Document Type: Article

References (41)

1. AHLEMEYER, B., MOWES, A. & KRIEGLSTEIN, J. (1999). Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur. J. Pharmacol., 367, 423-430.
2. AKIBA, S., CHIBA, M., MUKAIDA, Y. & SATO, T. (2003a). Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL. Biochem. Biophys. Res. Commun., 310, 491-497.
3. AKIBA, S., KAWAUCHI, T., OKA, T., HASHIZUME, T. & SATO, T. (1998). Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem. Mol. Biol. Int., 46, 1243-1248.
4. 2 to supply fatty acids required for cholesterol esterification. J. Lipid Res., 44, 1676-1685.
5. CARPENTER, K.L.H., WILKINS, G.M., FUSSELL, B., BALLANTINE, J.A., TAYLOR, S.E., MITCHINSON, M.J. & LEAKE, D.S. (1994). Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J., 304, 625-633.
6. CHANA, R.S. & WHEELER, D.C. (1999). Fibronectin augments monocyte adhesion to low-density lipoprotein-stimulated mesangial cells. Kidney Int., 55, 179-188.
7. CHEN, H.-C., GUH, J.-Y., SHIN, S.-J. & LAI, Y.-H. (2002). Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose. Atherosclerosis, 160, 141-146.
8. CHEN, S., MUKHERJEE, S., CHAKRABORTY, C. & CHAKRABARTI, S. (2003). High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1. Am. J. Physiol., 284, C263-C272.
9. CHEUNG, F., SIOW, Y.L., CHEN, W.Z. & O, K. (1999). Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem. Pharmacol., 58, 1665-1673.
10. CHEUNG, F., SIOW, Y.L. & O, K. (2001). Inhibition by ginkgolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC). Biochem. Pharmacol., 61, 503-510.
11. DEAN, D.C., BOWLUS, C.L. & BOURGEOIS, S. (1987). Cloning and analysis of the promoter region of the human fibronectin gene. Proc. Natl. Acad. Sci. U.S.A., 84, 1876-1880.
12. DEAN, D.C., MCQUILLAN, J.J. & WEINTRAUB, S. (1990). Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J. Biol. Chem., 265, 3522-3527.
13. DEFEUDIS, F.V. (1991). Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, pp. 61-96. Paris: Elsevier.
14. DIAMOND, J.R. (1991). Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int., 39 (Suppl 31), S29-S34.
15. HAYAMA, M., INOUE, R., AKIBA, S. & SATO, T. (2000). Inhibitory effect of cepharanthine on fibronectin production in growth factor-stimulated rat mesangial cells. Eur. J. Pharmacol., 390, 37-42.
16. 2 and PDGF in mesangial cells. Am. J. Physiol., 282, F485-F491.
17. IGLESIAS-DE LA CRUZ, M.C., RUIZ-TORRES, P., ALCAMÍ, J., DÍEZ-MARQUÉS, L., ORTEGA-VELÁZQUEZ, R., CHEN, S., RODRÍGUEZ-PUYOL, M., ZIYADEH, F.N. & RODRÍGUEZ-PUYOL, D. (2001). Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int., 59, 87-95.
18. KAMANNA, V.S. (2002). Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease. Histol. Histopathol., 17, 497-505.
19. KEANE, W.F., KASISKE, B.L. & O'DONNELL, M.P. (1988). Lipids and progressive glomerulosclerosis: a model analogous to atherosclerosis. Am. J. Nephrol., 8, 261-271.
20. KOBUCHI, H., DROY-LEFAIX, M.T., CHRISTEN, Y. & PACKER, L. (1997). Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem. Pharmacol., 53, 897-903.
21. LAMANT, V., MAUCO, G., BRAQUET, P., CHAP, H. & DOUSTE-BLAZY, L. (1987). Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem. Pharmacol., 36, 2749-2752.
22. LEE, B.-H., PARK, S.-Y., KANG, K.-B., PARK, R.-W. & KIM, I.-S. (2002). NF-κB activates fibronectin gene expression in rat hepatocytes. Biochem. Biophys. Res. Commun., 279, 1218-1224.
23. LEE, H.S., KIM, B.C., HONG, H.K. & KIM, Y.S. (1999). LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGFβ expression. Am. J. Physiol., 277, F369-F376.
24. LEE, Y.W., KÜHN, H., HENNIG, B., NEISH, A.S. & TOBOREK, M. (2001). IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J. Mol. Cell. Cardiol., 33, 83-94.
25. MAITRA, I., MARCOCCI, L., DROY-LEFAIX, M.T. & PACKER, L. (1995). Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol., 49, 1649-1655.
26. MARCOCCI, L., MAGUIRE, J.J., DROY-LEFAIX, M.T. & PACKER, L. (1994). The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun., 201, 748-755.
27. MASON, RM. & WAHAB, N.A. (2003). Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol., 14, 1358-1373.
28. PINCEMAIL, J., DUPUIS, M., NASR, C., HANS, P., HAAG-BERRURIER, M., ANTON, R. & DEBY, C. (1989). Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia, 45, 708-712.
29. REDDY, M.A., ADLER, S.G., KIM, Y.-S., LANTING, L., ROSSI, J., KANG, S.-W., NADLER, J.L., SHAHED, A. & NATARAJAN, R. (2002). Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am. J. Physiol., 283, F985-F994.
30. ROH, D.D., KAMANNA, V.S. & KIRSCHENBAUM, M.A. (1998). Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins. Am. J. Nephrol., 18, 344-350.
31. RONG, Y., GENG, Z. & LAU, B.H. (1996). Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. Free Radic. Biol. Med., 20, 121-127.
32. ROVIN, B.H. & TAN, L.C. (1993). LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int., 43, 218-225.
33. SHAH, SV. (1995). The role of reactive oxygen metabolites in glomerular disease. Annu. Rev. Physiol., 57, 245-262.
34. SHEN, J., WANG, J., ZHAO, B., HOU, J., GAO, T. & XIN, W. (1998). Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochim. Biophys. Acta, 1406, 228-236.
35. SUZUKI, M., ODA, E., NAKAJIMA, T., SEKIYA, S. & ODA, K. (1998). Induction of SpI in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene. Mol. Cell. Biol., 18, 3010-3020.
36. WANNER, C., GREIBER, S., KRÄMER-GUTH, A., HEINLOTH, A. & GALLE, J. (1997). Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a). Kidney Int., 52 (Suppl 63), S102-S106.
37. WHEELER, D.C., CHANA, R.S., TOPLEY, N., PETERSEN, M.M., DAVIES, M. & WILLIAMS, J.D. (1994). Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int., 45, 1628-1636.
38. YAGI, K. (1976). A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med., 15, 212-216.
39. YAN, L.J., DROY-LEFAIX, M.T. & PACKER, L. (1995). Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem. Biophys. Res. Commun., 212, 360-366.
40. YOSHIKAWA, T., NAITO, Y. & KONDO, M. (1999). Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid. Redox Signal., 1, 469-480.
41. ZHANG, W.R., HAYASHI, T., KITAGAWA, H., SASAKI, C., SAKAI, K., WARITA, H., WANG, J.M., SHIRO, Y., UCHIDA, M. & ABE, K. (2000). Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol. Res., 22, 517-521.